强大的酸衍生化合物阻止了Toxoplasma gondii tachyzoites的内基生态
Carlla Assis Araujo-Silva1, Katharina Vögerl2, Ferdinand Breu2
1Laboratório de Ultraestrutura Celular Hertha Meyer, Instituto de Biofísica Carlos Chagas Filho, Av. Carlos Chagas Filho, Centro de Pesquisa em medicina de Precisão, Universidade Federal do Rio de Janeiro, Cidade Universitária, Rio de Janeiro, RJ, 21941-904, Brazil; Instituto Nacional de Ciência e Tecnologia em Biologia Estrutural e Bioimagens, Universidade Federal do Rio de Janeiro, Brazil.
Experimental parasitology
|March 2, 2024
概括
新的酸盐化合物显示出针对Toxoplasma gondii扩散的选择性活性. 这些化合物破坏了太基细胞分裂,为新的毒素菌治疗提供了潜在的潜力.
科学领域:
- 寄生虫学的寄生虫学
- 药用化学 医学化学
- 分子生物学分子生物学
背景情况:
- 毒素菌是一种全球性的健康问题,特别是在胎儿和免疫力低下的人群中.
- 目前的治疗方法,如甲胺和硫法迪亚具有局限性,包括副作用和缺乏完整的寄生虫根除.
- 氨酸脱甲基酶 (KDACs) 存在于Toxoplasma gondii中,之前的研究表明酸类型KDAC抑制剂的有效性.
研究的目的:
- 评估三种新型酸盐化合物 (KV-24,KV-30,KV-46) 的疗效,这些化合物旨在抑制人类的KDAC6,对抗Toxoplasma gondii.
- 为了研究这些化合物对T. gondii tachyzoite增殖和细胞分裂的作用机制.
主要方法:
- 合成和表征三种含有异环环帽组和基结合剂的酸盐化合物.
- 在体外测试该化合物的活性,以防止T. gondii tachyzoite的扩散,确定IC50值.
- 显微镜分析观察细胞效应,包括囊细胞局部化,内膜复合组织和细胞分裂.
主要成果:
- 这三种酸化合物都对T. gondii表现出选择性活性,抑制了纳米分子范围内的tachyzoite增殖.
- 显微镜检测显示,在经过治疗的太基子体中,囊细胞错位,内膜复合物失调,并停止细胞分裂.
- 观察到分裂细胞与不完整的内生代的显著增加,表明干扰晚期细胞分裂.
结论:
- 新型酸盐化合物表现出强大和选择性的抗毒素菌活性.
- 这些化合物干扰T. gondii细胞分裂的关键步骤,表明有前途的治疗途径.
- 进一步的体内测试和这些胺酸的开发对于潜在的毒素菌治疗是有必要的.
相关概念视频
01:26Anticholinesterase Agents: Poisoning and Treatment
856
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
856
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.8K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.8K